I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Navidad-Fuentes, Miriam
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (3)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
Effectiveness of rituximab in a case of pleuropulmonary fib..:
Navidad-Fuentes, Miriam
;
Ramírez de la Torre, María
;
Quirosa-Flores, Susana
Medicina Clínica (English Edition). 158 (2022) 11 - p. e6-e7 , 2022
Link:
https://doi.org/10.1016/..
?
2
Reactive arthritis with SARS-COV-2 as a trigger:
Ruiz-del-Valle, Víctor
;
Sarabia de Ardanaz, Luis
;
Navidad-Fuentes, Míriam
..
Reumatología Clínica (English Edition). 18 (2022) 8 - p. 490-492 , 2022
Link:
https://doi.org/10.1016/..
?
3
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia De Ardanaz, Luis
;
Andreu-Ubero, Jose M.
;
Navidad-Fuentes, Miriam
...
Frontiers in Pharmacology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
4
Reactive arthritis with SARS-COV-2 as a trigger:
Ruiz-Del-Valle, Víctor
;
Sarabia de Ardanaz, Luis
;
Navidad-Fuentes, Míriam
..
http://hdl.handle.net/10668/22501. , 2022
Link:
http://hdl.handle.net/10..
?
5
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia De Ardanaz, Luis
;
Andreu-Ubero, Jose M
;
Navidad-Fuentes, Miriam
...
https://www.frontiersin.org/articles/10.3389/fphar.2021.620187/full. , 2021
Link:
http://hdl.handle.net/10..
?
6
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia De Ardanaz, Luis
;
Andreu-Ubero, Jose M
;
Navidad-Fuentes, Miriam
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281134/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
7
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia De Ardanaz, Luis
;
Andreu-Ubero, Jose M
;
Navidad-Fuentes, Miriam
...
1663-9812. , 2021
Link:
http://hdl.handle.net/10..
?
8
Table1_Tocilizumab in COVID-19: Factors Associated With Mor..:
Luis Sarabia De Ardanaz
;
Jose M. Andreu-Ubero
;
Miriam Navidad-Fuentes
...
doi:10.3389/fphar.2021.620187.s001. , 2021
Link:
https://doi.org/10.3389/..
?
9
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Luis Sarabia De Ardanaz
;
Jose M. Andreu-Ubero
;
Miriam Navidad-Fuentes
...
https://www.frontiersin.org/articles/10.3389/fphar.2021.620187/full. , 2021
Link:
https://doi.org/10.3389/..
?
10
Tocilizumab in COVID-19: Factors Associated With Mortality ..:
Sarabia de Ardanaz, Luis
;
Andreu Ubero, José María
;
Navidad Fuentes, Miriam
...
Sarabia De Ardanaz L. [et al.] (2021) Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment. Front. Pharmacol. 12:620187. doi: [10.3389/fphar.2021.620187]. , 2021
Link:
http://hdl.handle.net/10..
?
11
Table1_Tocilizumab in COVID-19: Factors Associated With Mor..:
Luis Sarabia De Ardanaz (11057778)
;
Jose M. Andreu-Ubero (11057781)
;
Miriam Navidad-Fuentes (11057784)
...
https://figshare.com/articles/dataset/Table1_Tocilizumab_in_COVID-19_Factors_Associated_With_Mortality_Before_and_After_Treatment_pdf/14890584. , 2021
Link:
https://doi.org/10.3389/..
1-11
